Hydrafacial Results Presentation Deck slide image

Hydrafacial Results Presentation Deck

Beauty Health delivered strong top-line growth in 2022 and EBITDA in line with guidance Eight consecutive quarters of double-digit topline growth 100 $98.1mm Q4 2022 net sales +26% growth YoY $16.3mm Q4 2022 adjusted EBITDA¹ +92% growth YoY ($3.8mm GAAP net income) 27 Double-digit YoY growth across all regions FY 2022 YoY growth: Americas: +44% APAC: +24% EMEA: +46% Global: +41% +48% 2018-2022 revenue CAGR² Outsized investment years now largely complete 1. Non-GAAP measure; refer to the disclaimer for a discussion of the definition of this measure and appendix for reconciliation to the most appropriate GAAP measure. 2. Excludes 2020 due to impact of COVID. Global infrastructure ready to scale Positioned to drive profitable growth in 2023 and beyond Continued momentum, confirms 2025 net sales and adjusted EBITDA margin targets BEAUTYHEALTH™
View entire presentation